Envista (NYSE:NVST) Price Target Raised to $18.00

Envista (NYSE:NVST) had its price target hoisted by Piper Sandler from $17.00 to $18.00 in a research note issued to investors on Monday,Benzinga reports. Piper Sandler currently has a neutral rating on the stock.

NVST has been the topic of a number of other research reports. Robert W. Baird boosted their price objective on shares of Envista from $17.00 to $22.00 and gave the company a “neutral” rating in a research report on Thursday, October 31st. Needham & Company LLC restated a “hold” rating on shares of Envista in a report on Thursday, October 31st. Wells Fargo & Company began coverage on Envista in a report on Tuesday, October 8th. They issued an “equal weight” rating and a $20.00 price objective for the company. Leerink Partners raised Envista from an “underperform” rating to a “market perform” rating and boosted their target price for the company from $16.00 to $23.00 in a research note on Thursday, October 31st. Finally, Stifel Nicolaus raised their price target on Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, Envista has a consensus rating of “Hold” and an average price target of $20.21.

Envista Stock Up 2.2 %

Shares of NYSE:NVST opened at $20.58 on Monday. Envista has a 12-month low of $15.15 and a 12-month high of $24.79. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. The stock’s 50-day moving average price is $20.00 and its 200-day moving average price is $19.09. The stock has a market capitalization of $3.54 billion, a P/E ratio of -2.65, a price-to-earnings-growth ratio of 1.82 and a beta of 1.34.

Envista (NYSE:NVST) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. On average, equities analysts anticipate that Envista will post 0.72 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the business. Iron Triangle Partners LP purchased a new stake in Envista in the third quarter worth about $43,262,000. Point72 Asset Management L.P. purchased a new stake in shares of Envista in the 3rd quarter worth approximately $37,559,000. Polar Asset Management Partners Inc. increased its position in Envista by 375.6% during the 3rd quarter. Polar Asset Management Partners Inc. now owns 1,497,250 shares of the company’s stock valued at $29,586,000 after buying an additional 1,182,450 shares in the last quarter. Franklin Resources Inc. raised its stake in Envista by 26.5% during the third quarter. Franklin Resources Inc. now owns 3,971,662 shares of the company’s stock valued at $78,480,000 after buying an additional 830,861 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC bought a new stake in Envista in the third quarter worth $14,965,000.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.